Relapse in stage I(E) diffuse large B-cell lymphoma

Nijland, M; Boslooper, K; van Imhoff, G; Kibbelaar, R; Joosten, P; Storm, H; van Roon, EN; Diepstra, A; Kluin-Nelemans, HC; Hoogendoorn, M

Nijland, M (reprint author), Univ Med Ctr Groningen, Dept Hematol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.

HEMATOLOGICAL ONCOLOGY, 2018; 36 (2): 416

Abstract

Despite a general favourable outcome in limited stage diffuse large B-cell lymphoma (DLBCL), relapses occur in about 10 to 20% of patients. Prognostic......

Full Text Link